Transaction · 0001062993-25-002547

PERCEPTIVE ADVISORS LLC

PERCEPTIVE ADVISORS LLC, DIR, reported a transaction classified as grant at Adagio Medical Holdings, Inc. involving 64167.000000 shares. Reported holdings after the transaction were 9675684.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
ADGMAdagio Medical Holdings, Inc.
Filing timeFeb 14
Trade dateJan 22, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

ADGM price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ADGM since 2025-02-14Filed 566 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001062993-25-002547
Common Stock
Transaction date
Jan 22, 2025
Filed Feb 14, 2025, 09:35 PM · 23d delay
Shares
64.1k sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
9.67M sh
Direct

Filing warnings

Notes recorded with this filing
2 warnings
delayed filingThe filing was reported 23 calendar days after the transaction date.
missing priceThe filing did not provide a usable price per share.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Direct Ownership
-30score
Filing-only score

-30

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    On January 22, 2025, the Reporting Persons were issued 64,167 shares of Common Stock of the Issuer at a price of $2.00 per share pursuant to the terms of the Convert Waiver, dated December 26, 2024, b…

  2. F2

    The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph…

  3. F3

    Directly held by C2 Life Sciences LLC ("C2"). The Advisor serves as the investment manager to C2.

Original filing · 0001062993-25-002547
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ADGM